CD8A and neoplasm: They promote angiogenesis via VEGF, promote tumor development and metastasis through cathepsin G and ROS, induce chronic inflammation by releasing TNF-α, IL-1β, IL-6, and IL-12, and inhibit effector CD8+ T cells (105).